About Acromion
Acromion GmbH is a privately held full-service CRO headquartered in Germany. Acromion supports biotechnology, pharmaceutical, medical device and diagnostics companies across the full scope of clinical trial execution. With a broad service portfolio from study development and clinical monitoring through biostatistics, data management and medical writing to quality management and clinical operations, Acromion accompanies complex study projects across the entire lifecycle.
As a full-service CRO, Acromion relies not only on delivering studies with operational excellence, but also managing them in an economically transparent and reliable way. Specialized software solutions such as Trialytix play a central role in securing efficiency, scalability and profitability in the dynamic day-to-day of clinical research.
The challenge
As a CRO, Acromion is faced every day with the task of precisely budgeting and efficiently managing complex and dynamic study projects without losing the overview of costs, revenues and resources.
In the past, budgeting, project management and financial administration were largely handled in Excel spreadsheets. With a growing number of studies running in parallel and their constantly changing conditions, this approach increasingly reached its limits and brought several recurring challenges:
High manual effort to maintain and reconcile numerous Excel spreadsheets
Many factors influencing the current budget status of studies
Difficult forecasting when conditions changed during the course of a study
Time-consuming cross-study analyses, e.g. on the utilization of departments or on the development of revenues and costs
The solution
With Trialytix, Acromion implemented a central software solution for budgeting, forecasting and financial controlling of clinical trial projects. The platform digitizes and automates central processes of financial and operational study administration and replaces Excel structures with an integrated system.
Key benefits of the solution:
Structured study budgets: Calculation, planning and tracking of study budgets including cost types, services and departments
Real-time transparency: Up-to-date KPIs on budget consumption, revenues, margin and cash flow – available at any time
Automated forecasts: Continuous projections based on progress, actual costs and planned services
Early warning system: Automatic alerts in the event of budget deviations, schedule risks or critical developments
Global reports: Cross-study analyses on liquidity, performance and resource utilization
Thanks to the intuitive user interface, even complex processes such as budget tracking and cost control can be mapped efficiently and clearly. Teams and departments receive a shared, reliable data basis and can react more quickly to changes. The real-time data and precise reporting tools support Acromion in making study projects more profitable and more efficient.
The goals at a glance
Digital process optimization: Replacement of many manual Excel processes with integrated budget, forecast and reporting functions.
Higher cost transparency: Ongoing budget control and early identification of deviations and cost drivers
Increasing study profitability: Optimized management of budgets, cash flow and resource deployment
Data-based decisions: Central dashboards and reports provide quick insights into financial details in order to make well-founded and precise management decisions.
Conclusion: more efficiency and transparency
With Trialytix, Acromion is fundamentally transforming the financial and operational management of its clinical studies. The platform enables transparent control of budgets, forecasts and performance and at the same time significantly reduces the administrative effort.
Real-time data, automated alerts and integrated budget functions enable decisions based on a data foundation that was previously not available in this form. This allows Acromion to focus more strongly on its core task: the successful, high-quality conduct of clinical studies.
Trialytix supports Acromion as a reliable partner and continuously evolves the platform – tailored precisely to the requirements of modern CROs and the rising complexity of clinical trial projects.